Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drugs”

309 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 309 results

Testing effectiveness (Phase 2)Temporarily pausedNCT02026362
What this trial is testing

Multiple Antigen Specific Cell Therapy (MASCT) for Hepatocellular Carcinoma(HCC) Patients After Radical Resection or Radio Frequency Ablation(RFA).

Who this might be right for
Hepatocellular Carcinoma
HRYZ Biotech Co. 100
Early research (Phase 1)Active Not RecruitingNCT01333046
What this trial is testing

Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL

Who this might be right for
Hodgkin LymphomaNon-Hodgkin LymphomaHodgkin Disease
Baylor College of Medicine 36
Early research (Phase 1)Ended earlyNCT00629876
What this trial is testing

A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.

Who this might be right for
Anemia
Takeda 2
Testing effectiveness (Phase 2)Study completedNCT02642965
What this trial is testing

Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Post Cytotoxic TherapyRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia
Children's Oncology Group 38
Testing effectiveness (Phase 2)Ended earlyNCT02677688
What this trial is testing

Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE)

Who this might be right for
Serologically Active Adult Systemic Lupus Erythematosus
Nantes University Hospital 9
Early research (Phase 1)Active Not RecruitingNCT00840853
What this trial is testing

Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Chronic Lymphocytic Leukemia (CLL)Non Hodgkin's Lymphoma
Baylor College of Medicine 68
Early research (Phase 1)Study completedNCT02588105
What this trial is testing

Study to Assess the Safety and Preliminary Efficacy of AZD0156 at Increasing Doses Alone or in Combination With Other Anti-cancer Treatment in Patients With Advanced Cancer

Who this might be right for
Advanced Solid Tumours
AstraZeneca 84
Not applicableStudy completedNCT01048372
What this trial is testing

Observational Study of Blood Treated With Cytolin

Who this might be right for
HIV Infections
CytoDyn, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT02076243
What this trial is testing

Treatment With Nab-paclitaxel in Cutaneous SCC

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai 2
Testing effectiveness (Phase 2)Looking for participantsNCT02479698
What this trial is testing

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Who this might be right for
Acquired Immunodeficiency SyndromeBK Virus InfectionHuman Immunodeficiency Virus+5 more
M.D. Anderson Cancer Center 100
Very early researchActive Not RecruitingNCT05634707
What this trial is testing

Evaluation of Fluoxetine and Cytotoxic Lysosomal Stress in Glioma (FLIRT)

Who this might be right for
Primary Brain TumorBrain Tumor, Recurrent
Duke University 10
Testing effectiveness (Phase 2)WithdrawnNCT03353428
What this trial is testing

Intervention of Engineered Immune Effector T Cells Against Lung Cancer

Who this might be right for
Lung CancerNSCLC
Shenzhen Geno-Immune Medical Institute
Early research (Phase 1)Ended earlyNCT00383097
What this trial is testing

Lmp1 and Lmp2 Specific CTLs Following Cd45 Antibody for Relapsed Ebv-Positive Hodgkin's Or Non-Hodgkin's Lymphoma

Who this might be right for
Hodgkins LymphomaNon-Hodgkin Lymphoma
Baylor College of Medicine 6
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05554419
What this trial is testing

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Arising From Previous Myeloproliferative Neoplasm+2 more
National Cancer Institute (NCI)
Very early researchLooking for participantsNCT04293042
What this trial is testing

Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients

Who this might be right for
BK Polyomavirus
Children's Hospital of Philadelphia 20
Early research (Phase 1)Looking for participantsNCT04013802
What this trial is testing

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Who this might be right for
Viral Infection
Baylor College of Medicine 47
Testing effectiveness (Phase 2)Ended earlyNCT01431794
What this trial is testing

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 23
Early research (Phase 1)Study completedNCT01144247
What this trial is testing

Cellular Immunotherapy Study for Brain Cancer

Who this might be right for
GliomasAnaplastic AstrocytomaAnaplastic Oligodendroglioma+3 more
Jonsson Comprehensive Cancer Center 10
Early research (Phase 1)UnknownNCT04193098
What this trial is testing

Study of Autologous Cytotoxic T Lymphocyte Immunotherapy Combination With PD-1 Inhibitor in the Advanced NSCLC

Who this might be right for
Non-small Cell Lung CancerSecond-line Treatment
Tianjin Medical University Cancer Institute and Hospital 10
Testing effectiveness (Phase 2)Study completedNCT02970981
What this trial is testing

Study of Combination of Ipilimumab and Nivolumab in Patients With Melanoma

Who this might be right for
Melanoma
NYU Langone Health 18
Load More Results
184